Senior insider sale
PRESIDENT AND CEO at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$204.9K
34.95K shares
What this filing means
AUERBACH ALAN H plans to sell 34.95K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $204.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/7/2026ACC: 0001959173-26-000194
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jul 2018
34.95K
Shares to sell
$204.9K
Approx. market value
18.01K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
1/2/2026
18.01KTotal acquired18.01K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2026 | Restricted Stock Vesting Compensation | 18.01K | — |
| Total | 18.01K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
16.94K
Market value
$99.0K
1/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
18.01K
Market value
$105.9K
1/7/2026
Total
Units
34.95K
Value
$204.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/6/2026 | 16.94K | $99.0K | — | Completed |
| Planned — Approximate Date | ||||
1/7/2026 | 18.01K | $105.9K | NASDAQ | Planned |
| Total | 34.95K | $204.9K | ||